Veterinary Specialty Hospital - Sorrento Valley
Specialty hospital / research center
3 current cancer treatment or research opportunities
About Veterinary Specialty Hospital - Sorrento Valley
Veterinary Specialty Hospital - Sorrento Valley is the participating hospital named in the current study listing below. The hospital is part of the Ethos Veterinary Health network, while Ethos Discovery coordinates the research program. Screening, enrollment and required visits are handled by the participating hospital; owners should confirm that the location is still enrolling before making travel plans.
Veterinary Specialty Hospital - Sorrento Valley official website →
Who the current listings are forDogs
Cancer types currently listedHemangiosarcoma, Lymphoma, Oral Melanoma
Where visits take placeVeterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Current options at Veterinary Specialty Hospital - Sorrento Valley
Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.
Gilvetmab treatment study for canine malignant melanoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Safety and efficacy study of gilvetmab in dogs with malignant melanoma; age ≥1 year.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 6.6; Active tumor required; Min age years: 1
Costs / coverage: 🟢 Fully funded. All study-related visits are covered at no cost to the pet owner.
Contact: Contact participating Ethos hospital through official study page.
Location
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Official study / enrollment information →
Investigational oral treatment for newly diagnosed canine B-cell lymphoma
Ethos Veterinary Health · USA
Now enrolling
What is being offered: Newly diagnosed, treatment-naïve B-cell lymphoma; >1 year; 22–100 lb.
Who may qualify: Confirmed cancer diagnosis required; Min age years: 1; Min weight lb: 22; Max weight lb: 100; Active tumor required
May not qualify if: Prior immunotherapy
Costs / coverage: 🟢 Fully funded. All study-related visits are covered at no cost to the pet owner.
Contact: Contact participating Ethos hospital through official study page.
Location
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Official study / enrollment information →
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Location
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Official study / enrollment information →
Before you contact the center
A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.
Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.
Check all options for your pet →
Free to use. No registration or paid report.
